FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

116089003: Cytarabine liposome (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
177356019 Cytarabine liposome en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
674830015 Cytarabine liposome (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cytarabine liposome Is a Product containing cytarabine (medicinal product) false Inferred relationship Some
Cytarabine liposome Is a Pyrimidine analog (substance) true Inferred relationship Some
Cytarabine liposome Is a Cytarabine (substance) false Inferred relationship Some
Cytarabine liposome Is a Liposomal agent (substance) true Inferred relationship Some
Cytarabine liposome This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. A substance that competes with, replaces or inhibits a specific metabolite of a cell and thereby interferes with the cell's normal metabolic functioning. true Inferred relationship Some
Cytarabine liposome This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Cytarabine (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing cytarabine liposome The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cytarabine liposome Inferred relationship Some
Cytarabine liposomal 50mg/5mL injection 5mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cytarabine liposome Inferred relationship Some
Cytarabine liposome only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cytarabine liposome Inferred relationship Some 1
Product containing only cytarabine liposome in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cytarabine liposome Inferred relationship Some 1
Product containing precisely cytarabine liposome 100 milligram and daunorubicin liposome 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cytarabine liposome Inferred relationship Some 1
Product containing precisely cytarabine liposome 100 milligram and daunorubicin liposome 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Cytarabine liposome Inferred relationship Some 1
Product containing only cytarabine liposome and daunorubicin liposome (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cytarabine liposome Inferred relationship Some 1
Product containing only cytarabine liposome and daunorubicin liposome in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cytarabine liposome Inferred relationship Some 1

Reference Sets

GB English

US English

Back to Start